- $1.41bn
- $1.31bn
- $550.42m
- 92
- 38
- 77
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 469 | 424 | 513 | 587 | 550 |
Cost of Revenue | |||||
Gross Profit | 158 | 139 | 185 | 211 | 191 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 415 | 379 | 436 | 494 | 475 |
Operating Profit | 53.8 | 45.1 | 76.5 | 93 | 75.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 50.3 | 45.5 | -60.9 | 80.7 | 75.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 36.1 | 34.7 | -41.9 | 59.6 | 60.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 36.1 | 34.7 | -41.9 | 59.6 | 60.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 36.1 | 34.7 | -41.9 | 59.6 | 60.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.25 | 1.11 | -1.26 | 1.89 | 2.1 |
Dividends per Share |